Assenagon Asset Management S.A. Aptinyx Inc. Transaction History

Assenagon Asset Management S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$0.35 - $0.72 $14,535 - $29,902	-41,531 Reduced 35.55%	75,283 $28,000
Q2 2022 Jul 27, 2022	BUY	$0.38 - $2.58 $18,420 - $125,068	48,476 Added 70.94%	116,814 $65,000
Q1 2022 Apr 25, 2022	BUY	$2.27 - $3.62 $155,127 - $247,383	68,338 New	68,338 $155,000
Q4 2021 Feb 01, 2022	SELL	$2.11 - $3.0 $27,282 - $38,790	-12,930 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$2.21 - $2.89 $36,655 - $47,933	-16,586 Reduced 56.19%	12,930 $30,000
Q2 2021 Jul 15, 2021	SELL	$2.39 - $3.5 $931,538 - $1.36 Million	-389,765 Reduced 92.96%	29,516 $84,000
Q1 2021 Apr 26, 2021	SELL	$2.86 - $4.33 $82,762 - $125,301	-28,938 Reduced 6.46%	419,281 $1.26 Million
Q4 2020 Feb 01, 2021	BUY	$2.93 - $4.3 $1.11 Million - $1.64 Million	380,364 Added 560.55%	448,219 $1.55 Million
Q3 2020 Oct 07, 2020	SELL	$3.05 - $4.99 $420,994 - $688,774	-138,031 Reduced 67.04%	67,855 $229,000
Q2 2020 Jul 21, 2020	BUY	$1.99 - $4.4 $379,847 - $839,863	190,878 Added 1271.84%	205,886 $859,000
Q1 2020 Apr 17, 2020	BUY	$1.81 - $5.03 $27,164 - $75,490	15,008 New	15,008 $32,000
Q3 2019 Oct 16, 2019	SELL	$3.0 - $4.08 $1.42 Million - $1.93 Million	-472,987 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$2.95 - $4.38 $1.4 Million - $2.07 Million	472,987 New	472,987 $1.58 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.